These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36708971)

  • 1. Micro-flow imaging multi-instrument evaluation for sub-visible particle detection.
    Fawaz I; Schaz S; Boehrer A; Garidel P; Blech M
    Eur J Pharm Biopharm; 2023 Apr; 185():55-70. PubMed ID: 36708971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variance Between Different Light Obscuration and Flow Imaging Microscopy Instruments and the Impact of Instrument Calibration.
    Matter A; Koulov A; Singh S; Mahler HC; Reinisch H; Langer C; Zucol B; Mathaes R
    J Pharm Sci; 2019 Jul; 108(7):2397-2405. PubMed ID: 30844365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
    Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A
    J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging.
    Sharma DK; Oma P; Pollo MJ; Sukumar M
    J Pharm Sci; 2010 Jun; 99(6):2628-42. PubMed ID: 20049937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
    Werk T; Volkin DB; Mahler HC
    Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmasking translucent protein particles by improved micro-flow imaging™ algorithms.
    Pedersen JS; Persson M
    J Pharm Sci; 2014 Jan; 103(1):107-14. PubMed ID: 24281987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.
    Akhunzada ZS; Hubert M; Sahin E; Pratt J
    Curr Pharm Biotechnol; 2019; 20(3):232-244. PubMed ID: 30767738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration.
    Guo S; Yu C; Guo X; Jia Z; Yu X; Yang Y; Guo L; Wang L
    J Pharm Sci; 2022 Apr; 111(4):1164-1171. PubMed ID: 34551350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging.
    Murphy MI; Bruque M; Hanford A; Trayton I; Handali M; Leissa JA; Hasige S; Day K; Patel SM
    J Pharm Sci; 2022 Jun; 111(6):1605-1613. PubMed ID: 35318031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Three Flow Imaging Microscopy Instruments for Image Analysis in Evaluating four Types of Subvisible Particle in Biopharmaceuticals.
    Nishiumi H; Deiringer N; Krause N; Yoneda S; Torisu T; Menzen T; Friess W; Uchiyama S
    J Pharm Sci; 2022 Nov; 111(11):3017-3028. PubMed ID: 35948157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of mammalian cell counts, cell size and cell health using the Moxi Z mini automated cell counter.
    Dittami GM; Sethi M; Rabbitt RD; Ayliffe HE
    J Vis Exp; 2012 Jun; (64):. PubMed ID: 22760092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interlaboratory comparison of sizing and counting of subvisible particles mimicking protein aggregates.
    Ripple DC; Montgomery CB; Hu Z
    J Pharm Sci; 2015 Feb; 104(2):666-77. PubMed ID: 25421933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.
    Gruia F; Parupudi A; Polozova A
    PDA J Pharm Sci Technol; 2015; 69(3):427-39. PubMed ID: 26048748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correcting the Relative Bias of Light Obscuration and Flow Imaging Particle Counters.
    Ripple DC; Hu Z
    Pharm Res; 2016 Mar; 33(3):653-72. PubMed ID: 26555667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection Capabilities.
    Ríos Quiroz A; Québatte G; Stump F; Finkler C; Huwyler J; Schmidt R; Mahler HC; Koulov AV; Adler M
    Anal Chem; 2015 Jun; 87(12):6119-24. PubMed ID: 26001042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and Flow Imaging Methods.
    Shibata H; Harazono A; Kiyoshi M; Ishii-Watabe A
    J Pharm Sci; 2022 Mar; 111(3):648-654. PubMed ID: 34619153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant.
    Frahm GE; Pochopsky AW; Clarke TM; Johnston MJ
    PLoS One; 2016; 11(2):e0150229. PubMed ID: 26925777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
    Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening techniques for monitoring the sub-visible particle formation of free fatty acids in biopharmaceuticals.
    Chen W; Klemm D; Gregoritza K; Satya Krishna Kishore R; Olaf Stracke J; Wurth C; Pinto C; Sancho Oltra N
    Eur J Pharm Biopharm; 2023 Sep; 190():242-247. PubMed ID: 37524212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.